COVID-19 has affected many of us; for some, the journey still hasn’t ended.

For the past four years, Tami has received a ton of questions about the intersection of COVID-19, long COVID, and fibromyalgia. Unfortunately, it’s been tough to find good answers with the spread of conflicting information and misinformation.

Today, Tami is excited to be joined by Dr. Keith Ellis, who’s here to answer our questions with science-backed information. There is a lot of common ground between fibromyalgia and the core symptoms of long COVID, and Dr. Ellis’ insights from his research and expertise as a medicinal chemist shed some light on how the broader interest in long COVID can benefit us as fibromyalgia patients.

In this conversation, Dr. Ellis and Tami discuss what COVID-19 is and how it affects the body, how COVID has changed over the years, the progression from acute COVID infection to developing long COVID symptoms, the rate of development of long COVID, the lack of effective prevention measures for long COVID, surprising demographics of those experiencing long COVID, the importance of a well-functioning immune system, differences Between Long COVID and fibromyalgia, core symptoms of long COVID, difficulties in diagnosing long COVID, Dr. Ellis’ background in medicinal chemistry and why he began his research into treatments for long COVID, a realistic timeline for drug development, the limited understanding of fibromyalgia mechanisms compared to those of long COVID, the need for more research funding for chronic illnesses like fibromyalgia, the microclot hypothesis and its relevance to long COVID symptoms, how breaking down microclots can facilitate recovery from long COVID, the problem with treating symptoms rather than underlying causes in chronic illnesses, the need to study individuals who have recovered from fibromyalgia, Dr. Ellis’ natural supplement to combat long COVID microclots, using mechanisms of action to find natural substitutes for pharmaceutical drugs, empowering patients with information and accessible solutions for chronic conditions, the lack of research and awareness around fibromyalgia in medical education, funding and research disparities for fibromyalgia versus other conditions, the overlap between long COVID and fibromyalgia diagnoses, the need for research to differentiate long COVID from fibromyalgia symptoms, Dr. Ellis’ thoughts on the future of treatment solutions for long COVID and fibromyalgia, and more.

Note: This episode is not meant to be medical advice. Every person and every situation is unique. The information you learn in this episode should be shared and discussed with your own healthcare providers.